[DPHARMA] QoQ Quarter Result on 31-Mar-2018 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
28-May-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Mar-2018 [#1]
Profit Trend
QoQ- -9.17%
YoY- 25.11%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 115,634 125,838 123,991 133,259 112,253 115,379 117,049 -0.80%
PBT 17,658 15,838 12,915 13,255 12,825 14,207 12,642 24.87%
Tax -3,289 -3,552 -2,576 -2,608 -1,057 -3,080 -3,001 6.28%
NP 14,369 12,286 10,339 10,647 11,768 11,127 9,641 30.38%
-
NP to SH 14,369 12,286 10,339 10,782 11,870 11,405 9,653 30.27%
-
Tax Rate 18.63% 22.43% 19.95% 19.68% 8.24% 21.68% 23.74% -
Total Cost 101,265 113,552 113,652 122,612 100,485 104,252 107,408 -3.83%
-
Net Worth 483,173 501,487 209,983 206,429 479,809 474,230 463,071 2.86%
Dividend
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Div 26,475 - 4,199 - 16,737 - 6,973 142.78%
Div Payout % 184.25% - 40.62% - 141.01% - 72.25% -
Equity
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Net Worth 483,173 501,487 209,983 206,429 479,809 474,230 463,071 2.86%
NOSH 661,881 661,881 650,902 278,959 278,959 278,959 278,959 77.61%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 12.43% 9.76% 8.34% 7.99% 10.48% 9.64% 8.24% -
ROE 2.97% 2.45% 4.92% 5.22% 2.47% 2.40% 2.08% -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
RPS 17.47 19.07 44.29 47.77 40.24 41.36 41.96 -44.15%
EPS 2.17 1.86 1.59 3.82 4.22 3.99 3.46 -26.66%
DPS 4.00 0.00 1.50 0.00 6.00 0.00 2.50 36.68%
NAPS 0.73 0.76 0.75 0.74 1.72 1.70 1.66 -42.08%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
RPS 12.01 13.07 12.88 13.84 11.66 11.99 12.16 -0.82%
EPS 1.49 1.28 1.07 1.12 1.23 1.18 1.00 30.35%
DPS 2.75 0.00 0.44 0.00 1.74 0.00 0.72 143.74%
NAPS 0.5019 0.5209 0.2181 0.2144 0.4984 0.4926 0.481 2.86%
Price Multiplier on Financial Quarter End Date
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Date 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 -
Price 0.95 1.23 1.30 2.80 2.53 2.20 2.25 -
P/RPS 5.44 6.45 2.94 5.86 6.29 5.32 5.36 0.98%
P/EPS 43.76 66.06 35.20 72.44 59.46 53.81 65.02 -23.14%
EY 2.29 1.51 2.84 1.38 1.68 1.86 1.54 30.18%
DY 4.21 0.00 1.15 0.00 2.37 0.00 1.11 142.61%
P/NAPS 1.30 1.62 1.73 3.78 1.47 1.29 1.36 -2.95%
Price Multiplier on Announcement Date
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Date 18/02/19 28/11/18 26/11/18 28/05/18 28/02/18 17/11/17 25/08/17 -
Price 1.03 1.07 1.08 3.35 2.97 2.20 2.03 -
P/RPS 5.90 5.61 2.44 7.01 7.38 5.32 4.84 14.07%
P/EPS 47.45 57.47 29.25 86.67 69.80 53.81 58.66 -13.15%
EY 2.11 1.74 3.42 1.15 1.43 1.86 1.70 15.44%
DY 3.88 0.00 1.39 0.00 2.02 0.00 1.23 114.63%
P/NAPS 1.41 1.41 1.44 4.53 1.73 1.29 1.22 10.10%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment